TrialReader


Evaluation of the Rotational Stability

NCT03247751 — Not applicable, Completed, 95 participants, Nidek Co. LTD.

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Rotational Stability of the Blue Light-absorbing Hydrophobic Acrylic Posterior Chamber Single Piece Intraocular Lens

RegistryNCT03247751
StatusCompleted
PhaseNot applicable
Study typeInterventional; na, single group, masking: none, treatment
Enrollment95 (Actual)
SponsorNidek Co. LTD. (Industry)
ConditionsCataract
Interventionsintraocular lens (Device)
Datesstart 2016-06-01, primary completion 2017-08-01, completion 2017-11-01, first posted 2017-08-14, last updated 2023-06-07

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Cataract All trials of intraocular lens

-Summary

To evaluate rotational stability of the investigational device implanted after cataract surgery.

Expand all sections  ·  Collapse all

+Detailed description

The primary endpoint is angle of intraocular lens rotation between the day of surgery and postoperative 6 months.

+Arms and interventions

ArmTypeInterventionsDescription
one groupExperimentalDevice: intraocular lensone group receiving NIDEK intraocular lens
  • intraocular lens (Device): Implant NIDEK intraocular lens after cataract surgery

+Outcome measures

Primary outcomes

  • The intraocular lens rotation [postoperative 6 months]: The angle of the intraocular rotation.

Secondary outcomes

  • visual acuity [postoperative 6 months]: Distance BCVA
  • Adverse event [postoperative 6 months]: severity and causal relationship

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Adults, 18 years or older
* Subject who diagnosed unilateral or bilateral age-related cataract.
* Potential postoperative BCVA of 0.2 log MAR (0.63) or better.
* Calculated IOL power in within the range of investigational IOL.
* Subject is able to understand, agree and sign the informed consent statement.
* Subject is able and willing to comply with the postoperative follow-up examination schedule.

Exclusion Criteria:

* Uncontrolled systemic or ocular disease.
* Extremely shallow anterior chamber.
* Previous intraocular and corneal surgery.
* Traumatic cataract.
* Pregnancy or lactation.
* Concurrent participation in another drug and device clinical investigation.

My Notes